Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione);Rosiglitazone Related CoMpound A;(5Z)-5-{[4-({2-[Methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione;2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methylene]-, (5Z)-;5Z-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methylene]-2,4-thiazolidinedione;Rosiglitazone Related Compound A ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methyli (1605828);(5Z)-5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]-phenyl]methylene]-2,4-thiazolidinedione
For laboratory research purposes. Not for drug or household use.
信号词
Warning
InChIKey
HCDYSWMAMRPMST-QINSGFPZSA-N
危险类别(旧)
H302,H315,H319,H335
存储要求
No data available,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage.
安全信息
危险品分类
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory system (Category 3)